Status:
UNKNOWN
Effect of Repeated Low-Level Red-Light Therapy on Visual Field Damage in Primary Open-angle Glaucoma
Lead Sponsor:
Zhongshan Ophthalmic Center, Sun Yat-sen University
Conditions:
Open Angle Glaucoma
Eye Diseases
Eligibility:
All Genders
18-69 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the effect of repeated low-level red-light therapy on existing visual field damages in primary open-angle glaucoma patients.
Detailed Description
Glaucoma is one of the main causes of visual impairment worldwide. Elevated intraocular pressure (IOP) is an important risk factor for glaucoma and the majority of anti-glaucoma therapies focus on the...
Eligibility Criteria
Inclusion
- Aged 18-69 years;
- Diagnosis of primary open-angle glaucoma with definite visual field defects in either eye (MD \<-3dB);
- Well-controlled IOP in both eyes (IOP\<21mmHg).
Exclusion
- Severe visual field defects in either eye (MD \<-22dB);
- Visual field defects caused by other diseases in either eye;
- Unreliable results of visual field or IOP measurements in either eye;
- Diagnosis of other ocular diseases in active phase in either eye;
- History of refractive surgeries in either eye;
- History of other ophthalmic laser treatments or intraocular surgeries in the last 3 months in either eye;
- Refusing to inform consents or having difficulties to take part in follow-ups in next 6 months.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05309811
Start Date
April 1 2022
End Date
September 30 2023
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China, 510060